Evidence mapPaperPMID 34923151Full record

ArticleProstaglandins & other lipid mediators2022

Ca

William D Hancock, Xiaoyong Lei, Gregory A Clines, Ying G Tusing, Susan E Nozell, Sasanka Ramanadham

Open access · greenAbstract read
In one paragraph

Article in Prostaglandins & other lipid mediators, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

William D HancockDepartment of Biochemistry and Molecular Biology Virginia Commonwealth University, Richmond, VA, USA.
Xiaoyong LeiDepartment of Cell, Developmental, and Integrative Biology, USA; Comprehensive Diabetes Center, University of Alabama at Birmingham, Birmingham, AL, USA.
Gregory A ClinesDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Ying G TusingDepartment of Cell, Developmental, and Integrative Biology, USA; Comprehensive Diabetes Center, University of Alabama at Birmingham, Birmingham, AL, USA.
Susan E NozellDepartment of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
Sasanka RamanadhamDepartment of Cell, Developmental, and Integrative Biology, USA; Comprehensive Diabetes Center, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: sramvem@uab.edu.
University of Alabama at Birmingham · USUniversity of Michigan · USVirginia Commonwealth University · US

Funding

University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Stuart J Frank · 2013 to 2026
$19.5M
UAB Core Center for Musculoskeletal DisordersP30AR046031 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NAGY, TIMOTHY R · 2001 to 2010
$5.6M
CALCIUM-INDEPENDENT PLA2BETA IN BETA-CELL APOPTOSISR01DK069455 · NIDDK · WASHINGTON UNIVERSITY · PI RAMANADHAM, SASANKA · 2004 to 2013
$2.7M
iPLA2beta-mediated alternative splicing and -cell death in type 1 diabetesR01DK126444 · NIDDK · UNIVERSITY OF VIRGINIA · PI CHALFANT, CHARLES E., EIZIRIK, DECIO LAKS · 2021 to 2024
$2.0M
Contribution of β-Cell- & Immune Cell-Derived Lipids to β-Cell Death and DiabetesR01DK110292 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RAMANADHAM, SASANKA · 2016 to 2019
$1.7M
Characterizing the Role of NF-kB in Promoting Glioma TumorigenicityR01CA138517 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NOZELL, SUSAN E · 2010 to 2014
$1.3M
Endothelin-1 and androgen in prostate cancer bone metastasis and bone healthI01BX001370 · VA · VETERANS HEALTH ADMINISTRATION · PI CLINES, GREGORY A · 2013 to 2024
BLRD Research Career Scientist Award ApplicationIK6BX004603 · VA · VA VETERANS ADMINISTRATION HOSPITAL · PI CHALFANT, CHARLES E. · 2019 to 2025
BLRD VA I01 BX001370BLRD VA IK6 BX004603NCI NIH HHS R01 CA138517NIAMS NIH HHS P30 AR046031NIDDK NIH HHS P30 DK079626NIDDK NIH HHS R01 DK069455NIDDK NIH HHS R01 DK110292NIDDK NIH HHS R01 DK126444
6 · The paper itself

Abstract

Bone modeling can be modulated by lipid signals such as arachidonic acid (AA) and its cyclooxygenase 2 (COX2) metabolite, prostaglandin E

Indexed as

Insulin-Secreting CellsOsteogenesisAnimalsBone and BonesDinoprostoneGroup VI Phospholipases A2MicePhospholipases A2DinoprostoneGroup VI Phospholipases A2Phospholipases A2Pla2g6 protein, mouseiPLA(2)βLipid-signalingOsteogenesisPGE(2)Runx2

Identifiers

PMID34923151
PMCPMC8753754
OpenAlexW4200618554

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.